Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Choroidal Neovascularization (CNV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04679935
What this trial is testing

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 52
Testing effectiveness (Phase 2)UnknownNCT02486484
What this trial is testing

Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection

Who this might be right for
NeovascularizationMacular DegenerationDiabetic Retinopathy+5 more
Rafic Hariri University Hospital 100
Post-approval studies (Phase 4)UnknownNCT02033018
What this trial is testing

Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization

Who this might be right for
Choroidal Retinal Neovascularization
Instituto de Olhos de Goiania 20
Large-scale testing (Phase 3)Study completedNCT00305630
What this trial is testing

Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)

Who this might be right for
Choroidal NeovascularizationAge-Related Macular Degeneration
Johns Hopkins University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05984927
What this trial is testing

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Elisigen, Inc. 20
Not applicableEnded earlyNCT02857894
What this trial is testing

Genetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated)

Who this might be right for
Choroidal Neovascularization
Fondation Ophtalmologique Adolphe de Rothschild 7
Large-scale testing (Phase 3)Study completedNCT00523406
What this trial is testing

Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)

Who this might be right for
Macular Degeneration
Medical University of Vienna 40
Large-scale testing (Phase 3)Study completedNCT05666804
What this trial is testing

Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy

Who this might be right for
Macular Polypoidal Choroidal Vasculopathy (PCV)
Novartis Pharmaceuticals 148
Post-approval studies (Phase 4)Study completedNCT02495181
What this trial is testing

Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Association for Innovation and Biomedical Research on Light and Image 50
Post-approval studies (Phase 4)Study completedNCT00135837
What this trial is testing

Photodynamic Therapy in Occult-Only Lesions (POOL)

Who this might be right for
Age-Related Macular Degeneration
Novartis 202
Testing effectiveness (Phase 2)Study completedNCT04290195
What this trial is testing

Use of Ziv Aflibercept in Different Retinal Diseases

Who this might be right for
Central Retinal Vein Occlusion With Macular Edema
Amin El Sayed Nawar 55
Post-approval studies (Phase 4)Study completedNCT03393767
What this trial is testing

Time Course of Activity Signs at SD-OCT High Frequency Intravitreal Ranibizumab Treatment in CNV Due to AMD

Who this might be right for
Choroidal NeovascularizationAge Related Macular Degeneration
Vista Klinik 30
Testing effectiveness (Phase 2)Study completedNCT02537054
What this trial is testing

Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)

Who this might be right for
Pseudoxanthoma Elasticum
University Hospital, Bonn 15
Early research (Phase 1)UnknownNCT00695682
What this trial is testing

Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)

Who this might be right for
Diabetic RetinopathyMacular Degeneration
Retina Research Foundation 4
Not applicableStudy completedNCT01666821
What this trial is testing

A Population-based Study of Macular Choroidal Neovascularization in a Chinese Population

Who this might be right for
Geographic AtrophyWet Macular DegenerationRetinal Drusen
Shanghai University of Traditional Chinese Medicine 59
Not applicableStudy completedNCT02381730
What this trial is testing

Assessment of Visual Acuity in Patients With Polypoidal Choroidal Vasculopathy and Aflibercept Treatment

Who this might be right for
Polypoidal Choroidal Vasculopathy
Fondation Ophtalmologique Adolphe de Rothschild 37
Not applicableUnknownNCT04119219
What this trial is testing

Antiangiogenic Therapy of CNV Associated With Angioid Streaks

Who this might be right for
Angioid Streaks of Macula
The Filatov Institute of Eye Diseases and Tissue Therapy 100
Not applicableStudy completedNCT00656903
What this trial is testing

High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 75
Testing effectiveness (Phase 2)Ended earlyNCT03452527
What this trial is testing

Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationWet Macular Degeneration
Iconic Therapeutics, Inc. 15
Testing effectiveness (Phase 2)UnknownNCT01790893
What this trial is testing

Treatment for Presumed Ocular Histoplasmosis

Who this might be right for
Ocular Histoplasmosis
John Kitchens, MD 40
Next Page